人血清中A、C、Y、W135群腦膜炎球菌莢膜多糖IgG抗體含量ELISA檢測方法的建立
[Abstract]:Aim to establish a ELISA method for quantitative determination of anti A, C, Y, W135 meningococcal capsule polysaccharide Ig G antibody in human serum and verify it. Methods the suitable enzyme plate was screened, the concentration of antigen coated was optimized, the key conditions of ELISA detection process were determined, and the specificity, linearity, accuracy, precision, minimum detection value and stability of the established ELISA method were verified. And establish the laboratory quality control serum quality control detection range. Results the intraplate CV and inter-plate CV were 9.8% and 16.4% respectively. There was a significant dose-dependent relationship between the group-specific antibody content and the absorbed dose of the same-group polysaccharide. There was a negative correlation between the content of each group of Ig-G antibody and the dilution of the serum in the 12 CDC quality-controlled sera of the United States. The correlation coefficient (r) and slope (slope) are both close to-1, and the linear relationship is good. The correlation coefficients A, C, W135 and Y were 0.912, 0.939 6, 0.963 7 and 0.920 6, respectively. The results were in good agreement with CDC published data. The intra-and inter-test precision of each group of Ig-G antibody in the internal quality control serum Men20 was less than 10% and 20%, respectively, and the precision was better, the CV value of each serum group was 30%, and the stability was good. The lowest detection values of Ig G antibody in A, C, Y, W135 polysaccharide groups were 0.092, 0.118, 0.067 and 0.035 渭 g / ml, respectively, the detection ranges were 92.49 渭 g / ml, 37.29 渭 g / ml., 66.18 渭 g / ml. and 50.15 ~ 23.31 渭 g / ml., respectively. Conclusion A standardized ELISA method was established for the determination of anti-A, C, Y, W135 group meningococcal polysaccharide Ig G antibody in human serum, and the range of quality control detection value of Men20 in laboratory routine quality control serum was determined. [WT5 "HZ] conclusion\ [WT5" BZ]
【作者單位】: 蘭州生物制品研究所有限責任公司甘肅省疫苗工程技術(shù)研究中心;中國食品藥品檢定研究院;美國阿拉巴馬大學伯明翰分校病理學系呼吸道病原參考實驗室;中國生物技術(shù)股份有限公司;
【基金】:國家科技支撐計劃課題(2008BAI66B01) 國家“重大新藥創(chuàng)制”專項(2013ZX09402-302-215) 甘肅省科技重大專項(0801NKDA003) 甘肅省“十二五隴藥產(chǎn)業(yè)發(fā)展”專項
【分類號】:R378.15;R392-33
【相似文獻】
相關(guān)期刊論文 前10條
1 鮑莉;;各種靜脈注射用免疫球蛋白制品的特征:Ⅰ.蛋白成份和抗體含量[J];國外醫(yī)學.生物制品分冊;1983年02期
2 周學良;;人初乳中抗霍亂抗體的保護力[J];國外醫(yī)學.生物制品分冊;1983年03期
3 高建煒;曹守勤;郝瓊;閆立群;;2006年寧夏三市健康人群血清流腦抗體含量分析[J];寧夏醫(yī)學雜志;2008年07期
4 王曉明,鄭霞清,龍存國,張國元,李秋茹;急性閉合性顱腦損傷患者血清髓鞘堿性蛋白及其抗體含量的研究[J];臨床神經(jīng)病學雜志;1997年04期
5 李紅;唐靜;李茂光;李亞南;何莉;葉強;;ELISA方法測定血清中Hib多糖抗體含量的條件比較研究[J];微生物學免疫學進展;2009年01期
6 許秀芳;Rieben R;;體外循環(huán)保存離體豬肢體實驗中IgG和IgM抗體含量變化的研究[J];心肺血管病雜志;2008年04期
7 程金華;;應(yīng)用ELISA方法檢測老年動脈粥樣硬化患者血清抗負電性低密度脂蛋白自身抗體含量[J];中國老年學雜志;2012年16期
8 韓曉芳,宋壯志,李慧君,王文灝,吳翠平,杜英,梁建林;SARS患者特異性抗體水平的動態(tài)監(jiān)測[J];中華醫(yī)院感染學雜志;2004年11期
9 ;[J];;年期
10 ;[J];;年期
相關(guān)會議論文 前1條
1 張晟;羅弟祥;劉怡;何剛;李劍紅;高小平;;抗體含量檢測的生物膜干涉技術(shù)、HPLC及ELISA的比較[A];2012年中國藥學大會暨第十二屆中國藥師周論文集[C];2012年
,本文編號:2442796
本文鏈接:http://sikaile.net/yixuelunwen/binglixuelunwen/2442796.html